cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Werewolf Therapeutics Inc
2 own
4 watching
Current Price
$5.9
$0.03
(0.51%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
122.85M
52-Week High
52-Week High
8.19400
52-Week Low
52-Week Low
1.57400
Average Volume
Average Volume
0.12M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization122.85M
icon52-Week High8.19400
icon52-Week Low1.57400
iconAverage Volume0.12M
iconDividend Yield--
iconP/E Ratio--
What does the Werewolf Therapeutics Inc do?
Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapeutics engineered to stimulate the body s immune system for the treatment of cancer. The company, through its proprietary PREDATOR platform, designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional proinflammatory immune therapies. Its lead product candidates are WTX-124, a conditionally activated Interleukin-2 INDUKINE molecule for the treatment of advanced solid tumors; and WTX-330, a conditionally activated Interleukin-12 INDUKINE molecule for the treatment of relapsed or refractory advanced or metastatic solid tumors or lymphoma. The company is also developing WTX-613, a conditionally activated interferon alpha INDUKINE molecule for the treatment of solid tumors and hematologic malignancies. Werewolf Therapeutics, Inc. was incorporated in 2017 and is headquartered in Cambridge, Massachusetts.
Read More
How much money does Werewolf Therapeutics Inc make?
News & Events about Werewolf Therapeutics Inc.
Globe Newswire
1 year ago
WATERTOWN, Mass., April 19, 2023 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (the Company or Werewolf) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development of conditionally activated therapeutics, announced the publication in Cancer Immunology Research Online First ...
Globe Newswire
1 year ago
WATERTOWN, Mass., March 16, 2023 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (the Company or Werewolf) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development of conditionally activated therapeutics engineered to stimulate the bodys immune system for the treatment of ...
Globe Newswire
1 year ago
WTX-330 is designed as systemically delivered, conditionally activated IL-12 therapy Phase 1 Study of WTX-330 is intended to evaluate the safety, tolerability, and clinical activity of WTX-330 in Patients with Advanced or Metastatic Solid Tumors orNon-Hodgkin Lymphoma Second clinical stage program ...
Ticker Report
1 year ago
Werewolf Therapeutics, Inc. (NASDAQ:HOWL Get Rating) Director Ra Capital Management, L.P. purchased 1,853,000 shares of the firms stock in a transaction on Friday, January 6th. The shares were purchased at an average cost of $2.21 per share, with a total value of $4,095,130.00. ...
PR Newswire
1 year ago
Thinking about buying stock in Biora Therapeutics, AMC Entertainment, Werewolf Therapeutics, Broadwind, or BioNano Genomics? Thinking about buying stock in Biora Therapeutics, AMC Entertainment, Werewolf Therapeutics, Broadwind, or BioNano Genomics? PR Newswire NEW YORK, Jan. 11, 2023 NEW YORK...
Frequently Asked Questions
Frequently Asked Questions
What is Werewolf Therapeutics Inc share price today?
plus_minus_icon
Can Indians buy Werewolf Therapeutics Inc shares?
plus_minus_icon
How can I buy Werewolf Therapeutics Inc shares from India?
plus_minus_icon
Can Fractional shares of Werewolf Therapeutics Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Werewolf Therapeutics Inc stocks?
plus_minus_icon
What is today’s traded volume of Werewolf Therapeutics Inc?
plus_minus_icon
What is today’s market capitalisation of Werewolf Therapeutics Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Werewolf Therapeutics Inc?
plus_minus_icon
What percentage is Werewolf Therapeutics Inc down from its 52-Week High?
plus_minus_icon
What percentage is Werewolf Therapeutics Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$5.9
$0.03
(0.51%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00